Catalyst Wire Dossier Catalyst Wire Dossier

Debio 025

alisporivir · Debiopharm International SA
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Debio 025, covering 2015-05-07 to 2016-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients [NA]

See pricing